Skip to main content

Table 1 Comparison of sociodemographic and clinical characteristics between type 2 diabetes patients with and without MVC

From: Achievement of treatment goals for secondary prevention of myocardial infarction or stroke in 29,325 patients with type 2 diabetes: a German/Austrian DPV-multicenter analysis

  Patients with type 2 diabetes without macrovascular complication (MI, or stroke) (n = 172,834) Patients with type 2 diabetes and at least one macrovascular complication (MI, or stroke) (n = 29,325) p*
  n   n  
Men,  % 172,834 50.3 29,325 57.6 <0.0001
Age (years) 172,834 69.9 (59.6;77.5) 29,325 73.6 (66.5;79.8) <0.0001
Age at diagnosis (years) 172,834 59.1 (49.2;68.6) 29,325 62.2 (52.7;70.5) <0.0001
Diabetes duration (years) 172,834 7.8 (2.6;13.8) 29,325 9.8 (4.2;16.0) <0.0001
BMI (kg/m2) 152,737 29.9 (26.3;34.5) 26,044 29.0 (25.8;32.9) <0.0001
HbA1C (%) 156,314 7.1 (6.2;8.4) 27,091 6.9 (6.2;8.2) <0.0001
Systolic BP (mmHg) 161,233 130.0 (120.0;144.0) 28,368 130.0 (120.0;140.0) <0.0001
Diastolic BP (mmHg) 161,073 80.0 (70.0;80.0) 28,345 75.0 (70.0;80.0) <0.0001
Total Chol (mg/dl) 122,629 187.0 (156.0;221.0) 23,645 171.0 (143.0;205.0) <0.0001
LDL-Chol (mg/dl) 109,060 111.0 (85.0;139.0) 22,328 99.0 (76.0;128.0) <0.0001
HDL-Chol (mg/dl) 111,496 43.0 (35.0;54.0) 22,389 42.0 (34.0;51.0) <0.0001
Physical inactivity,  % 59,410 90.0 11,293 92.5 <0.0001
Smoking, yes,  % 121,303 12.5 23,448 9.4 <0.0001
Cigarettes per day 15,173 14 (10;20) 2213 15 (10;20) 0.0975
  1. Data are medians (Q1;Q3) unless otherwise indicated
  2. * p values adjusted for multiple comparisons by FDR